Abstract
To investigate whether testosterone administration alters natriuretic peptide levels in women. Three-month, double-blind, randomized, placebo-controlled study. Clinical research center. Fifty-one women with hypoandrogenemia due to hypopituitarism. Transdermal testosterone (300 μg daily) or placebo patch. N-Terminal pro-B-type natriuretic peptide (NT-proBNP) levels. NT-proBNP levels decreased in the transdermal testosterone group compared with placebo over three months. The difference between groups remained significant after controlling for baseline age, systolic blood pressure, body mass index, and homeostasis model assessment of insulin resistance. Change in NT-proBNP over 3 months was inversely associated with change in free testosterone levels. Testosterone administration to women results in decreased natriuretic peptide levels, suggesting that testosterone may be an inverse regulator of the natriuretic peptide system. NCT00027430.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
